Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Immunoregulatory antigens-novel targets for cancer immunotherapy
Ayako Wakatsuki Pedersen
*
, Katharina L Kopp,
Mads Hald Andersen
, Mai-Britt Zocca
*
Corresponding author for this work
3
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immunoregulatory antigens-novel targets for cancer immunotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Immunotherapy
100%
Immunomodulatory
100%
Tumor Antigen
60%
Immune Suppression
40%
T Cells
40%
Vaccination
20%
Indoleamine 2,3-dioxygenase 1 (IDO1)
20%
Immune-suppressive
20%
In Cancer
20%
Effector T Cell Response
20%
Cancer Vaccine
20%
Clinical Phases
20%
Dual Mode of Action
20%
Direct Killing
20%
Programmed Death-ligand 1 (PD-L1)
20%
Checkpoint Blockade
20%
Suppressive Function
20%
New Targets
20%
Control Cell
20%
Antitumor
20%
Cancer Types
20%
Autoreactive T Cells
20%
Cancer Development
20%
Phase I Trial
20%
Cancer Patients
20%
Recent Advances
20%
Evidence Support
20%
Tumor Cells
20%
Antigen-specific T Cells
20%
Medicine and Dentistry
Cancer Immunotherapy
100%
T Cell
100%
Tumor Antigen
75%
Immunosuppressive Treatment
50%
Neoplasm
25%
Antigen Specificity
25%
Immune Response
25%
Indoleamine 2,3 Dioxygenase
25%
Immunity
25%
Specific Tumor
25%
Tumor Vaccine
25%
T-Cell Response
25%
Tumor Cell
25%
Cancer Types
25%
Programmed Death-Ligand 1
25%
Malignant Neoplasm
25%
Phase I Trials
25%
Immunology and Microbiology
Cancer Immunotherapy
100%
T Cell
100%
Tumor Antigen
60%
Immunity
60%
Tumor Vaccine
20%
Tumor Cell
20%
Immune Response
20%
Antigen Specificity
20%
Indoleamine 2,3-dioxygenase
20%
Programmed Death-Ligand 1
20%